Zobrazeno 1 - 10
of 237
pro vyhledávání: '"Jan J.G.M. Verschuuren"'
Autor:
Donnie Cameron, Tooba Abbassi‐Daloii, Laura G.M. Heezen, Nienke M. van deVelde, Zaïda Koeks, Thom T.J. Veeger, Melissa T. Hooijmans, Salma elAbdellaoui, Sjoerd G. vanDuinen, Jan J.G.M. Verschuuren, Maaike vanPutten, Annemieke Aartsma‐Rus, Vered Raz, Pietro Spitali, Erik H. Niks, Hermien E. Kan
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 3, Pp 1546-1557 (2023)
Abstract Background Becker muscular dystrophy (BMD) is an X‐linked disorder characterized by slow, progressive muscle damage and muscle weakness. Hallmarks include fibre‐size variation and replacement of skeletal muscle with fibrous and adipose t
Externí odkaz:
https://doaj.org/article/84afed761ba3440388f7e0cb12ace4c1
Autor:
Kevin R. Keene, Hermien E. Kan, Stijn van derMeeren, Berit M. Verbist, Martijn R. Tannemaat, Jan‐Willem M. Beenakker, Jan J.G.M. Verschuuren
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 6, Pp 2820-2834 (2022)
Abstract Ophthalmoparesis and ptosis can be caused by a wide range of rare or more prevalent diseases, several of which can be successfully treated. In this review, we provide clues to aid in the diagnosis of these diseases, based on the clinical sym
Externí odkaz:
https://doaj.org/article/ed6781bda9e8467fa3e12eea8a4db0ee
Autor:
Karin J. Naarding, Kevin R. Keene, Aashley S.D. Sardjoe Mishre, Thom T.J. Veeger, Nienke M. van deVelde, Arina J. Prins, Jedrzej Burakiewicz, Jan J.G.M. Verschuuren, Menno van derHolst, Erik H. Niks, Hermien E. Kan
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 3, Pp 694-703 (2021)
Abstract Background Clinical trials in Duchenne muscular dystrophy (DMD) focus primarily on ambulant patients. Results cannot be extrapolated to later disease stages due to a decline in targeted muscle tissue. In non‐ambulant DMD patients, hand fun
Externí odkaz:
https://doaj.org/article/26d2999fe15a4b3dac887ede12e33b30
Autor:
Kevin R. Keene, Irene C. Notting, Jan J.G.M. Verschuuren, N. Voermans, Ronald. O.B. de Keizer, Jan-Willem M. Beenakker, Martijn R. Tannemaat, Hermien E. Kan
Publikováno v:
Journal of Neuromuscular Diseases. :1-15
Introduction: MRI of extra-ocular muscles (EOM) in patients with myasthenia gravis (MG) could aid in diagnosis and provide insights in therapy-resistant ophthalmoplegia. We used quantitative MRI to study the EOM in MG, healthy and disease controls, i
Autor:
Jana Koers, Rocco Sciarrillo, Ninotska I.L. Derksen, Esther M. Vletter, Yvonne E. Fillié-Grijpma, Elisabeth Raveling-Eelsing, Nuno A.G. Graça, Thiemo Leijser, Hendri H. Pas, L. Laura van Nijen-Vos, Maaike V.J. Braham, Anne-Marie Buisman, Jan de Jong, Angela I. Schriek, Anne P. Tio-Gillen, Y.K. Onno Teng, Maurice Steenhuis, Francis H. Swaneveld, Steven W. de Taeye, Marit J. van Gils, Jan J.G.M. Verschuuren, Bram Rutgers, Peter Heeringa, Barbara Horváth, Bart C. Jacobs, Karina de Leeuw, Casper F.M. Franssen, Agnès Veyradier, Paul Coppo, Kyra A. Gelderman, S. Marieke van Ham, Cécile A.C.M. van Els, Diane van der Woude, Ruth Huizinga, Maartje G. Huijbers, Taco W. Kuijpers, Rene E.M. Toes, Nicolaas A. Bos, Theo Rispens
Publikováno v:
Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. MOSBY-ELSEVIER
Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. Mosby Inc.
Journal of allergy and clinical immunology, 151(6), 1646-1654. Mosby Inc.
T2B Consortium 2023, ' Differences in IgG autoantibody Fab glycosylation across autoimmune diseases ', Journal of Allergy and Clinical Immunology, vol. 151, no. 6, pp. 1646-1654 . https://doi.org/10.1016/j.jaci.2022.10.035
Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. Mosby Inc.
Journal of allergy and clinical immunology, 151(6), 1646-1654. Mosby Inc.
T2B Consortium 2023, ' Differences in IgG autoantibody Fab glycosylation across autoimmune diseases ', Journal of Allergy and Clinical Immunology, vol. 151, no. 6, pp. 1646-1654 . https://doi.org/10.1016/j.jaci.2022.10.035
Background: Increased prevalence of autoantibody Fab glycosylation has been demonstrated for several autoimmune diseases. Objectives: To study whether elevated Fab glycosylation is a common feature of autoimmunity, this study investigated Fab glycosy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5813e3dc93eee892ef693f3c417e2f1
https://research.rug.nl/en/publications/53202de0-8a76-4930-ae74-692d30576434
https://research.rug.nl/en/publications/53202de0-8a76-4930-ae74-692d30576434
Autor:
Jan J.G.M. Verschuuren, Jos G.M. Hendriksen, Lotte Heutinck, Edith H. C. Cup, Erik H. Niks, Imelda J. M. de Groot, Yvonne D. Krom, Michèl A.A.P. Willemsen, Saskia L.S. Houwen-van Opstal, Merel Jansen
Publikováno v:
Muscle & Nerve, 64(6), 701-709. WILEY
Muscle and Nerve, 64, 6, pp. 701-709
Muscle and Nerve, 64, 701-709
Muscle and Nerve, 64, 6, pp. 701-709
Muscle and Nerve, 64, 701-709
Contains fulltext : 244841.pdf (Publisher’s version ) (Open Access) INTRODUCTION/AIMS: As life expectancy improves for patients with Duchenne muscular dystrophy (DMD), new symptoms are likely to arise. This aims of this study are: (1) to explore th
Autor:
Erik H. Niks, Hermien E. Kan, Erik W. van Zwet, Jan J.G.M. Verschuuren, Karin J. Naarding, Imelda J. M. de Groot, Menno van der Holst, Nienke M van de Velde
Publikováno v:
Neurology, 97, E1737-E1742
Neurology, 97, 17, pp. E1737-E1742
Neurology, 97(17), E1737-E1742. LIPPINCOTT WILLIAMS & WILKINS
Neurology
article-version (Version of Record) 3
Neurology, 97, 17, pp. E1737-E1742
Neurology, 97(17), E1737-E1742. LIPPINCOTT WILLIAMS & WILKINS
Neurology
article-version (Version of Record) 3
Background and ObjectivesTo study the potential of quantitative MRI (qMRI) fat fraction (FF) as a biomarker in nonambulant patients with Duchenne muscular dystrophy (DMD), we assessed the additive predictive value of elbow flexor FF to age at loss of
Autor:
Alexander C. H. Geurts, Imelda J. M. de Groot, Merel Jansen, Jan J.G.M. Verschuuren, Maaike van Gameren, Lotte Heutinck
Publikováno v:
Journal of Neuromuscular Diseases, 8, 4, pp. 503-512
Journal of Neuromuscular Diseases, 8(4), 503-512. IOS PRESS
Journal of Neuromuscular Diseases, 8, 503-512
Journal of Neuromuscular Diseases
Journal of Neuromuscular Diseases, 8(4), 503-512. IOS PRESS
Journal of Neuromuscular Diseases, 8, 503-512
Journal of Neuromuscular Diseases
Background: In order to successfully implement the international clinical care guidelines for Duchenne muscular dystrophy (DMD) in the Netherlands, it is essential to know what barriers are experienced by healthcare practitioners regarding guideline
Publikováno v:
Neuromuscular Disorders, 31(7), 612-621. PERGAMON-ELSEVIER SCIENCE LTD
Fatigue is usually defined as a subjective perception of lacking energy, mentally or physically, with a difficulty sustaining voluntary activities. It is a common symptom of many diseases and most likely has a multifactorial cause. In myasthenia grav
Autor:
Volker Straub, Jennifer E. Morgan, Thomas Voit, Valeria Ricotti, Laurent Servais, Joana Domingos, Jan J.G.M. Verschuuren, L. Phillips, Imelda J. M. de Groot, Francesco Muntoni, Pierpaolo Ala, V. Selby, Andreea Mihaela Seferian, Erik H. Niks, D. Scaglioni, Yvonne D. Krom, F. Catapano, K. Maresh
Publikováno v:
Epigenomics, 12, 1899-1915
Epigenomics, 12, 21, pp. 1899-1915
Epigenomics, 12(21), 1899-1915. FUTURE MEDICINE LTD
Epigenomics, 12, 21, pp. 1899-1915
Epigenomics, 12(21), 1899-1915. FUTURE MEDICINE LTD
Item does not contain fulltext Aim: To perform cross-sectional and longitudinal miRNA profiling in plasma from Duchenne muscular dystrophy (DMD) subjects and find non-invasive biomarkers in DMD. Subjects/materials & methods: Plasma was collected from